Continuous Neonatal Blood Gas Monitoring Using a Multiparameter Intra-Arterial Sensor

Abstract

Conclusions-Continuous MPIAS ABG monitoring is an exciting development, with the potential to reduce blood transfusions and improve ABG homeostasis. (Arch Dis Child Fetal Neonatal Ed 1999;80:F93-F98)

Reduction in Red Blood Cell Transfusions Using a Bedside Analyzer in Extremely Low Birth Weight Infants

“…In summary, the results of this study suggest that use of newer, bedside devices can help reduce blood transfusions. Since the use of the iSTAT unlike other in-line POC devices [9][10][11][12][13][14]32 does not require the presence of an arterial catheter, it can potentially contribute towards reducing phlebotomy losses and blood transfusions throughout the infant's hospital stay.…”

Continuous Monitoring of Fetal pH, pO₂ and pCO₂ Using a Fiberoptic Multiparameter Sensor in Animal Models Reproducing in utero Conditions

“…Furthermore, this method provides continuous measurements that can easily be stored and enhances the early detection of minimal changes and trend analysis. This technique has been tested successfully in neonatal, pediatric, and adult intensive care and surgery [7][8][9][10][11]. To the best of our knowledge, this is the first report on the feasibility and accuracy of fiberoptic multiparameter sensing in fetal monitoring.…”

“…Fiberoptic sensors are now commercially available including the Neotrend ® multiparameter intravascular sensor (MPIS) used in this study. It provides continuous measurements of pO 2 , pCO 2 , pH, and temperature and has been successfully used in both adult and neonatal intensive care situations [7,8]. Validation of the accuracy of this sensor has been demonstrated in vivo in the physiologic range for postnatal values [5,[9][10][11] but never focussed on the low range of pO 2 present in fetal life.…”

Congenital diaphragmatic hernia: prenatal diagnosis permits immediate intensive care with high survival rate in isolated cases. A population‐based study

“…In the NICU, some babies were moved to Sensormedics 3100A respirator (SensorMedics Corporation, Yorba Linda, California, USA) to perform highfrequency oscillation (HFO) when hypoxemia or hypercarbia were not controlled with Dräger 8000+ ventilator on HFV. Ventilation adjustment was based on data from the Neotrend device which have been shown accurate by Morgan et al (1999). Permissive hypercarbia (PaCO2 < 7O mmHg) (Acute Respiratory Distress Syndrome (ARDS) Network, 2000) was rarely useful, since HFO was available.…”